Galectin Therapeutics Inc (NASDAQ: GALT) on Friday, soared 9.46% from the previous trading day, before settling in for the closing price of $5.71. Within the past 52 weeks, GALT’s price has moved between $0.73 and $6.66.
Healthcare Sector giant saw their annual sales slid by -23.89% over the last five years. The company achieved an average annual earnings per share of 35.53%. With a float of $45.90 million, this company’s outstanding shares have now reached $64.47 million.
Galectin Therapeutics Inc (GALT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Galectin Therapeutics Inc is 28.84%, while institutional ownership is 15.94%. The most recent insider transaction that took place on Dec 12 ’25, was worth 122,993. Before that another transaction happened on Dec 08 ’25, when Company’s Director sold 159,000 for $5.98, making the entire transaction worth $950,105. This insider now owns 11,206 shares in total.
Galectin Therapeutics Inc (GALT) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.19 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.16) by -0.03.
According to the Wall Street analysts, stocks earnings will be around 35.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.03% during the next five years compared to -23.89% drop over the previous five years of trading.
Galectin Therapeutics Inc (NASDAQ: GALT) Trading Performance Indicators
Galectin Therapeutics Inc (GALT) is currently performing well based on its current performance indicators. A quick ratio of 0.09 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Galectin Therapeutics Inc (GALT)
Analysing the last 5-days average volume posted by the [Galectin Therapeutics Inc, GALT], we can find that recorded value of 0.75 million was better than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 45.94%.
During the past 100 days, Galectin Therapeutics Inc’s (GALT) raw stochastic average was set at 89.32%, which indicates a significant increase from 73.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was higher than the 0.40 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.41, while its 200-day Moving Average is $3.24. Now, the first resistance to watch is $6.59. This is followed by the second major resistance level at $6.92. The third major resistance level sits at $7.45. If the price goes on to break the first support level at $5.73, it is likely to go to the next support level at $5.20. Should the price break the second support level, the third support level stands at $4.87.
Galectin Therapeutics Inc (NASDAQ: GALT) Key Stats
Market capitalization of the company is 403.00 million based on 64,473K outstanding shares. Right now, sales total 0 K and income totals -47,050 K. The company made 0 K in profit during its latest quarter, and -8,180 K in sales during its previous quarter.
